指南与共识慢阻肺哮喘

中国稳定期慢性气道疾病吸入装置规范应用专家共识(2023)

[Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
指南 / 共识 · Zhonghua Jie He He Hu Xi Za Zhi · 2023-01-01

我国慢性气道疾病负担沉重,吸入疗法为一线基础治疗,但装置选择与使用不当常见。本共识由相关学组组织专家基于最新循证证据修订2019版,系统阐述不同吸入装置特性、患者评估、个体化选择、装置切换、教育随访等,以规范吸入装置应用、提高疗效与依从性。

要点

  • 吸入装置、患者、医护人员三方面均显著影响吸入给药有效性。
  • 装置选择应基于患者吸气峰流量、手肺协调能力、操作能力与偏好。
  • 每次随访应定期复核并纠正吸入技术,仅靠说明书不足以充分教育患者。

核心结论

  • 共识系统规范了稳定期慢性气道疾病吸入装置的个体化选择、切换、教育与随访,以改善疾病控制与预后并减少医疗资源浪费。

研究设计与样本

  • 由中国医学装备协会呼吸病学装备专业委员会吸入治疗与呼吸康复学组及中国慢阻肺联盟组织专家,基于最新循证医学证据与临床诊疗经验修订2019版专家共识。

主要发现

  • 慢性气道疾病可影响呼吸道解剖与生理结构,进而影响药物吸入与递送。
  • 装置自身因素包括主动或被动释放、气溶胶特性及装置内部阻力可影响吸入给药有效性。
  • 患者因素中吸气能力、装置正确使用(吸入技术)及规律定量吸入(治疗依从性)对达标至关重要。
  • 医护人员通过评估患者吸气能力与偏好、掌握装置特性、合理选择、培训吸入技术及指导装置更换可影响疗效与依从性。
  • 深吸气量、延长屏气时间、气道廓清及减少上气道弯曲与阻力可进一步提高吸入药物疗效。

关键数值与推荐

  • 推荐用主动释放装置(推荐短效支气管舒张剂吸入装置)检测患者手肺协调性,首次使用或使用不正确者指导后复测。
  • 检测患者吸气峰流量及能否以30 L/min持续吸入3秒,备选评估方法为用吸管持续吃酸奶。
  • 手肺协调好且能以30 L/min(或以上)持续吸入超过3秒者可选用任何吸入装置。
  • 手肺协调差但吸气峰流量达30 L/min者可选用DPI或加储雾罐的主动释放装置。
  • 手肺协调好、吸气峰流量小于30 L/min且持续吸气超过3秒者可选用SMI或加储雾罐的主动释放装置。

临床怎么用

  • 按手肺协调性、吸气峰流量与持续吸气能力分层为患者个体化选择吸入装置。
  • 装置切换需明确指征,切换后应解释必要性、重新培训并加强随访反馈。
  • 每次就诊定期复核并纠正吸入技术,不能仅依赖装置说明书教育患者。
  • 随访管理包括评估疗效、纠正操作技术与促进依从性。
  • 慢性气道疾病患者处于呼吸道传染病流行风险时,吸入装置使用应严格遵守防控要求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence of chronic airway diseases in China has been increasing every year, resulting in a high burden of disease. Inhalation therapy is widely used as a basic first-line treatment for such diseases. However, inappropriate selection of inhalation devices and usage methods is common, leading to poor disease control and prognosis, as well as a waste of medical resources. In order to facilitate the reasonable selection and appropriate use of inhaler devices, improve the efficacy of inhalation therapy, and increase patient compliance, the Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment, and Chinese Chronic Obstructive Pulmonary Disease Coalition organized experts to revise the Chinese expert consensus on standardized inhaler device application in stable chronic respiratory disease patients (2019 Edition) based on the latest evidence-based medical evidence and clinical diagnosis and treatment experience.Chronic airway diseases can affect the anatomical and physiological structure of the respiratory tract, which can affect the inhalation and delivery of drugs. In order to achieve the maximum effect of inhaled drugs, it is necessary for the drugs to be completely released from the device and to be deposited in the peripheral airways. Therefore, inhaler devices, patients, and medical staff can have a significant impact on the effectiveness of inhalation administration. The effectiveness of inhalation administration is influenced by several factors related to the inhaler device itself, including active or passive release, aerosol characteristics, and internal device resistance. For patients, the inhalation ability, the correct use of inhaler devices (inhalation technique), and regular and quantitative inhalation (treatment compliance) are essential to achieve the desired therapeutic effect. Medical staff can influence the efficacy and compliance of patients through proper assessment of their inhalation capacity and preferences, knowledge of different inhaler device characteristics, rational selection of inhaler devices, training in inhalation techniques, and guidance on inhaler device replacement. Standardized education can help minimize operational errors and improve patients' ability to use inhaler devices effectively. In addition, deep inspiratory volume, prolonged breath-hold time, airway clearance, and reduction of upper airway curvature and resistance can further improve the efficacy of inhaled drugs. The choice of inhalation device should be based on the patient's inspiratory flow rate, hand-lung coordination ability, device operation ability, and preference.The revised consensus version provides a clear understanding of the characteristics and operating principles of different types of inhaler devices, including pressurized metered-dose inhaler (pMDI), dry powder inhaler (DPI), soft mist inhaler (SMI), and small-volume nebulizers (SVN). The consensus categorizes pMDI as traditional pMDI (solution type, suspension type, and co-suspension type), extra-fine pMDI, and breath-actuated pMDI; and DPI into capsule, reservoir, and blister types. The inhalation device is evaluated based on three dimensions: drug delivery, device operation, and other characteristics. The indicators to assess drug delivery characteristics include lung deposition, oropharyngeal deposition, aerosol duration, aerosol plume velocities, MMAD, fine particle fractions, and dose repeatability. The indicators used to assess the operational device characteristics include inspiratory flow rate requirements, hand-breath coordination requirements, inspiratory synchronous drive, pre-use shaking, and operational steps. Other characteristic indicators include avoidance of humidity exposure, storage environment requirements, propellant, carrying convenience, counter, cleaning, and medication type. The consensus provides a detailed introduction to the personalized selection, switching, education, and follow-up of inhaler devices.1. Establishing a Chinese consensus on the individualized selection of inhaler devices for patients based on the characteristics of different devices includes the following steps:(1) Testing the patient's hand-breath coordination using an active release inhaler device (recommended: a short-acting bronchodilator inhaler). If the device is being used for the first time or is not being used correctly, it should be re-tested after instruction.(2) Testing the patient's peak inspiratory flow rates and whether they can consistently inhale at an inspiratory flow rate of 30 L/min for 3 seconds (an alternative assessment method is to continue eating yoghurt through a straw).(3) Assessing the need for non-invasive ventilation in patients with poor hand-breath coordination.(4) Based on the evaluation results, the recommendations for different inhaler devices are as follows:① Patients with good hand-breath coordination and the ability to inhale consistently at an inspiratory flow rate of 30 L/min (or more) for more than 3 seconds can use any inhaler device; ② Patients with poor hand-breath coordination who can achieve a peak inspiratory flow rate of 30L/min can use DPI or an active release device with a Spacer; ③ Patients with good hand-breath coordination, a peak inspiratory flow rate less than 30 L/min, and a constant inspiratory flow for more than 3 seconds can use SMI or an active release device with a Spacer; ④ Patients with poor hand-breath coordination, a peak inspiratory flow rate less than 30 L/min, and a constant inspiratory flow for more than 3 seconds can use SMI and an active release device with a Spacer; ⑤ Patients with a peak inspiratory flow rate less than 30 L/min and a constant inspiratory flow for less than 3 seconds can use an active release device with a Spacer; ⑥ Patients who require non-invasive ventilation can use an active release device and nebulizers(Active release devices include pMDI and SMI).2. Switching inhaler devices:The need to switch inhaler devices should be clear, and there are indications for switching:(1) inhaled drugs has been changed or added because of the patient's condition, requiring delivery by another inhaler device.(2) the patient was unable to use the inhaler device correctly after several training attempts.(3) patients were dissatisfied with the inhaler device and had poor adherence.(4) the patient used the device correctly, but the therapeutic effect was unsatisfactory.Once the decision to switch the inhaler device has been made, the following steps should be taken:(1) explain the necessity of switching the inhaler device.(2) retrain the patient in the use of the new inhaler device.(3) intensify follow-up to obtain patient feedback on the use of the new device and to check inhalation technique, drug consumption and efficacy.3. Education on inhalation technique:It is crucial to educate patients on proper inhalation technique. Teaching patients how to use inhaler devices in a standardized way is an important measure to ensure that they use the devices correctly. This helps to improve the accuracy of inhaler device operation, patient adherence, disease control, and reduce disease burden. Relying solely on the instructions provided with the inhaler device is not sufficient to adequately educate patients, and patients' inhalation technique may unintentionally change over time, resulting in decreased efficacy. Inhalation technique should be regularly reviewed and corrected at each visit.4. Follow-up of inhalation therapy:Follow-up management is a crucial part of maximizing patient efficacy, including assessing efficacy, correcting operation techniques, and promoting adherence.5. Other:When patients with chronic airway diseases are at risk of respiratory epidemic infectious diseases, the use of inhaler devices should strictly comply with the requirements for the prevention and control of such diseases. 我国慢性气道疾病的发病率逐年上升,疾病负担沉重。吸入疗法作为慢性气道疾病的一线基础疗法临床应用广泛,然而吸入装置的个性化选择及其使用方法均普遍存在不正确的现象,直接影响疾病控制及预后,甚至造成医疗资源的浪费。为了帮助医生和患者合理选择吸入装置和正确掌握吸入装置的使用方法,提高吸入治疗的疗效和患者的依从性,本共识立足最新循证医学证据,结合临床诊疗经验,在《稳定期慢性气道疾病吸入装置规范应用中国专家共识(2019版)》的基础上进行了修订,不仅阐明了不同类型吸入装置的特性及其工作原理,帮助医务人员进行个体化选择,同时对患者进行吸入方法的培训,有助于患者疗效最大化,提高患者吸入治疗依从性。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37914418. doi:10.3760/cma.j.cn112147-20230411-00167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。